Your browser doesn't support javascript.
loading
Evaluation of a new recombinant oncolytic vaccinia virus strain GLV-5b451 for feline mammary carcinoma therapy.
Adelfinger, Marion; Gentschev, Ivaylo; Grimm de Guibert, Julio; Weibel, Stephanie; Langbein-Laugwitz, Johanna; Härtl, Barbara; Murua Escobar, Hugo; Nolte, Ingo; Chen, Nanhai G; Aguilar, Richard J; Yu, Yong A; Zhang, Qian; Frentzen, Alexa; Szalay, Aladar A.
Afiliação
  • Adelfinger M; Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany.
  • Gentschev I; Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany; Genelux Corporation, San Diego Science Center, San Diego, California, United States of America.
  • Grimm de Guibert J; Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany.
  • Weibel S; Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany.
  • Langbein-Laugwitz J; Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany.
  • Härtl B; Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany; Genelux GmbH, Bernried, Germany.
  • Murua Escobar H; Small Animal Clinic, University of Veterinary Medicine, Hannover, Germany; Division of Medicine Clinic III, Hematology, Oncology and Palliative Medicine University of Rostock, Rostock, Germany.
  • Nolte I; Small Animal Clinic, University of Veterinary Medicine, Hannover, Germany.
  • Chen NG; Genelux Corporation, San Diego Science Center, San Diego, California, United States of America; Department of Radiation Medicine and Applied Sciences, Rebecca & John Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, California, United States of America.
  • Aguilar RJ; Genelux Corporation, San Diego Science Center, San Diego, California, United States of America.
  • Yu YA; Genelux Corporation, San Diego Science Center, San Diego, California, United States of America; Department of Radiation Medicine and Applied Sciences, Rebecca & John Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, California, United States of America.
  • Zhang Q; Genelux Corporation, San Diego Science Center, San Diego, California, United States of America; Department of Radiation Medicine and Applied Sciences, Rebecca & John Moores Comprehensive Cancer Center, University of California San Diego, La Jolla, California, United States of America.
  • Frentzen A; Genelux Corporation, San Diego Science Center, San Diego, California, United States of America.
  • Szalay AA; Department of Biochemistry, University of Wuerzburg, Wuerzburg, Germany; Genelux Corporation, San Diego Science Center, San Diego, California, United States of America; Division of Medicine Clinic III, Hematology, Oncology and Palliative Medicine University of Rostock, Rostock, Germany; Department o
PLoS One ; 9(8): e104337, 2014.
Article em En | MEDLINE | ID: mdl-25093734
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vaccinia virus / Neoplasias Mamárias Animais / Vírus Oncolíticos / Vetores Genéticos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vaccinia virus / Neoplasias Mamárias Animais / Vírus Oncolíticos / Vetores Genéticos Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: PLoS One Assunto da revista: CIENCIA / MEDICINA Ano de publicação: 2014 Tipo de documento: Article País de afiliação: Alemanha